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Innate immunity: Lipoproteins take their Toll on the host
Charles A. Janeway, Jr and Ruslan Medzhitov
A family of mammalian Toll-like receptors (TLRs) has a
critical role in the recognition of microbial infection.
Recent evidence suggests that bacterial lipoproteins —
major components of bacterial cell walls — are
recognized by a member of the human TLR family.
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The recognition of infecting microbes followed by the
induction of an effective immune response is essential
for the survival of most multicellular organisms. It is
equally important, however, that the immune response
is not induced upon the recognition of self antigens, or
non-infectious, innocuous, non-self antigens. So, how
does the immune system decide which antigens to
respond to and which to ignore? We believe that the
immune system must somehow be able to determine the
origin of the antigens, such that only the antigens of
microbial origin would induce immune responses,
whereas self antigens and non-microbial, non-self anti-
gens would not. The antigens themselves, however,
have no special features that are intrinsically associated
with their origin and, indeed, conventional T and B lym-
phocytes are not preprogrammed to recognize just
microbial antigens. 
It has been suggested [1] that host organisms detect the
presence of infection by recognizing a limited number of
conserved structures produced only by micro-organisms
and not by multicellular hosts. These structures are
referred to as pathogen-associated molecular patterns
(PAMPs) and their recognition is followed by the induc-
tion of inflammatory responses required for the recruit-
ment and activation of lymphocytes. Receptors that
recognize these molecular patterns have been an impor-
tant missing link in connecting the detection of infection
with the activation of antigen-specific lymphocytes. A
family of mammalian receptors, called Toll-like receptors
(TLRs), has recently been identified [2,3] that appears to
perform just this function. The identification of TLRs
prompted many researchers to test their favorite PAMPs
for recognition by individual members of the Toll family.
Three recent reports [4–6] provide evidence that bacter-
ial lipoproteins — one of the major PAMPs produced by
all bacteria — are recognized by a particular member of
the TLR family, TLR2.
Mammalian TLRs, as the name implies, are homologs of
the Drosophila Toll protein, which was originally identi-
fied as a receptor involved in the control of dorso-ventral
pattern formation in fly embryos [7]. Both Drosophila and
mammalian Toll receptors are transmembrane proteins
with a large extracellular domain that contains multiple
leucine-rich repeats. The receptors also contain a cytoplas-
mic domain homologous to that of the interleukin-1 (IL-1)
receptor, and therefore referred to as a TIR domain, for
Toll/IL-1 receptor homology domain (Figure 1). The sim-
ilarities between members of the Toll family and
members of the IL-1 receptor family are not restricted to
their structure, however, because both families induce the
activation of the transcription factor NF-κB and share
many components of the NF-κB signaling pathway [8].
The first evidence of the involvement of Toll signaling in
host defense came from the analysis of immune responses
in Drosophila mutants carrying loss-of-function mutations in
various components of the Toll pathway [9]. As it turned
out, flies deficient in several individual components of the
Toll signaling pathway were unable to recognize fungal
infection and produce drosomycin, a major antifungal
peptide [9]. More recently, another member of the
Drosophila Toll family, 18-Wheeler, has been demonstrated
to be involved in the recognition of bacterial infection [10]. 
Microbial infection in Drosophila and other insects results in
a rapid induction of a battery of antimicrobial peptides that
kill pathogens by punching holes in their cell walls [11].
Importantly, individual peptides have selective activity
against a particular class of micro-organisms — for
example, gram-positive or gram-negative bacteria, or
fungi — and infection with a given class of pathogens
results in the preferential induction of only the appropri-
ate peptides [12]. As the induction of the different
antimicrobial peptides is likely to be controlled by indi-
vidual members of the Toll family, it appears that in
Drosophila the Toll receptors not only detect the presence
of infection, but also discriminate between different
classes of pathogens.
The recent studies of the human and mouse TLRs suggest
an intriguing possibility that the ability of Toll receptors to
recognize a particular pathogen class may have been con-
served in mammals. Indeed, mouse TLR4 has been shown
to be a receptor for lipopolysaccharide — a major PAMP
associated with gram-negative bacteria [13–15]. Moreover,
a mouse strain that carries a spontaneous loss-of-function
mutation in the tlr4 gene demonstrates selective suscep-
tibility to gram-negative bacterial infections [13,14].
Additionally, biochemical data suggest that another member
of the Toll family, TLR2, is involved in the recognition of
gram-positive bacteria, probably by recognizing peptidogly-
can, a PAMP found in all bacteria, but only exposed for
recognition in the gram-positive microbes [16,17]. 
The most compelling evidence for a differential role of
TLRs in pathogen class recognition comes from the com-
parative analysis of TLR2- and TLR4-deficient mice [18].
A detailed characterization of lipopolysaccharide respon-
siveness in these mice clearly demonstrates that, at least in
the mouse, TLR2 is not necessary for the lipopolysaccha-
ride responses. Indeed, the susceptibility to endotoxic
shock, cytokine production, and the activation of signaling
pathways induced by lipopolysaccharide are normal in the
TLR2 knockout mice, whereas all these responses are com-
pletely eliminated in the TLR4-deficient mice [18]. Con-
versely, in the TLR2 knockout mice, the cellular responses
to gram-positive bacterial cell walls are severely impaired,
and the responses to peptidoglycan are eliminated com-
pletely, whereas these responses are normal in the TLR4
knockout mice [18]. These results indicate that TLR2 is
involved in the recognition of peptidoglycan and gram-posi-
tive bacteria, and TLR4 is specialized for the recognition of
lipopolysaccharide and, therefore, gram-negative bacteria. 
Surprisingly, however, cells derived from mice deficient
in TLR4, but not TLR2, are also unresponsive to lipotei-
choic acid — a PAMP found only in gram-positive bacte-
ria [18]. This is a very important finding that suggests
that different TLRs may have evolved to recognize
PAMPs that have similar structural patterns rather than a
common microbial origin. Indeed, the molecular pattern
of lipoteichoic acid is quite similar to lipopolysaccharide
and completely distinct from peptidoglycan. It is perhaps
premature to make this generalization, however, given
the recent publications that add bacterial lipoproteins to
the growing number of PAMPs recognized by mam-
malian TLRs [4–6]. These lipoproteins are found in all
bacteria and share a common chemical motif — cova-
lently bound, highly hydrophobic acyl groups. Interest-
ingly, as with lipopolysaccharide, the lipid moiety of
bacterial lipoproteins is necessary for their function in
bacteria and for their recognition by the host’s innate
immune system [19]. This reflects the strategy of the
innate immune system to recognize molecular patterns
essential for the survival of the micro-organisms, thus pre-
venting the generation of escape mutants that would
therefore lack the ability to cause infection. 
Several types of experiments have revealed that bacterial
lipoproteins signal through human TLR2: first, expression
of TLR2 in TLR2-negative cell lines confers responsive-
ness to bacterial lipoproteins; second, a TLR2-specific
monoclonal antibody blocks bacterial lipoprotein-induced
cell signaling; and third, expression of a dominant-nega-
tive inhibitory form of TLR2 blocks the response to bac-
terial lipoproteins [4–6]. Finally, and most convincingly,
responses induced by bacterial lipoproteins are completely
eliminated in cells derived from the TLR2 knockout mice
(S. Akira, personal communication). There are two key
implications of these findings. Unlike lipopolysaccharide
and lipoteichoic acid, bacterial lipoproteins are not
restricted to any particular type of bacteria, and TLR2-
mediated recognition of bacterial lipoproteins may there-
fore not discriminate between different classes of bacteria.
Also, bacterial lipoproteins do not share any obvious struc-
tural patterns with peptidoglycans, suggesting that at least
some TLRs can be involved in the recognition of chemi-
cally unrelated PAMPs. The recent data implicating
TLR2 in the recognition of zymosan [20], a component of
yeast cell walls, lend support to both of these points: on
the one hand, zymosan is structurally unrelated to both
peptidoglycan and bacterial lipoproteins; on the other
hand, given that it is a yeast molecule, zymosan does not
share a common microbial origin with peptidoglycan and
bacterial lipoproteins, which are present only in bacteria.
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Figure 1
TLRs recognize pathogen-associated molecular patterns (PAMPS) that
often represent molecular signatures of a particular pathogen class:
LPS (lipopolysaccharide) is a product of gram-negative bacteria; BLP
(bacterial lipoproteins) are found in all bacteria; LTA (lipoteichoic acid)
is a product of gram-positive bacteria; peptidoglycan is present in both
gram-positive and gram-negative bacteria, but is exposed for
recognition only in gram-positive bacteria; LAM (lipoarabinomannan) is
a product of mycobacteria; and mannans and glucans are products of
yeast cell walls. Recognition of these various molecules by TLRs on
antigen-presenting cells activates the expression of various factors that
lead to inflammatory responses and the induction of adaptive immunity.
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At this stage, it is evident that the role of TLR2 in the
recognition of infection is far from being completely
resolved. The demonstration that TLR2 knockout mice
do not have any obvious defects in responses to
lipopolysaccharide and lipoteichoic acid [18] is clearly at
odds with previously published reports implicating
human TLR2 in the recognition of these molecules
[17,21,22]. There is also something unsettling in the fact
that the same receptor (TLR2) has been found to be
involved in the recognition of lipopolysaccharide
[21–24], lipoteichoic acid, peptidoglycan [16,17], bacter-
ial lipoproteins [4–6], and lipoarabinomannan [25] in
studies performed in vitro. At the same time, TLR2 does
not seem to be necessary for lipopolysaccharide recogni-
tion in a hamster cell line [26], whereas both mouse and
human TLR4 seem to mediate lipopolysaccharide sig-
naling [13–15,23,24].
It is unclear at present whether these discrepancies
reflect species-specific differences in TLR recognition,
or perhaps some subtle flaws in the experimental design
of the in vitro studies. The latter may be due to any one
of a number of factors. Overexpression of TLRs may
have some non-specific effect on the responsiveness of
the reporter cell lines. Also, most (but not all) reports
lack some essential control experiments: for example,
when expression of a wild-type or a dominant-negative
version of TLR2 is used to confer or inhibit responsive-
ness to a particular stimulus, a proper control would be
the use of wild-type or dominant-negative forms of TLR
other than TLR2. 
The response monitored in most reports is the activation
of NF-κB, which may not always reflect the physiological
cellular responses mediated by TLRs: for example,
lipopolysaccharide can still activate NF-κB in mice that
lack the Toll/IL-1 signaling adaptor molecule MyD88
and are defective in TLR2 and TLR4 signaling. The cel-
lular responses, however, as measured by cytokine pro-
duction and the induction of septic shock, are completely
eliminated in these animals [27]. The reason for the lack
of correlation between NF-κB activation and the induc-
tion of NF-κB-dependent inflammatory cytokines in
these mice is currently unknown, but possibly suggests
that NF-κB activation, although necessary, may not be
an adequate ‘read-out’ for TLR activation. Finally, it
should be emphasized that at present we do not really
know the identity of the actual ligands for any of the
TLRs. It may well be that, as with Drosophila Toll, mam-
malian TLRs do not recognize PAMPs directly, but lie
on a pathway downstream of the actual pattern recogni-
tion event. If this is the case, the gene products involved
in the generation of the ligands may be differentially
expressed in the various cell lines used for the in vitro
studies, thus accounting for the observed discrepancies
in the TLR specificities.
Thus, the field of the TLRs is in its infancy. It will be
necessary to generate mice deficient in several more
TLRs to study their specific and shared ligands.
Upstream and downstream modifiers of pathogen
responses also need to be characterized. It may be that it
is not simply one TLR that tells the adaptive immune
system what kind of pathogen is on the premises, but that
some kind of integrated signal informs the host adaptive
immune system what kind of response is needed to
combat the particular pathogen. As an example, we found
that, although both TLR4 and IL-1 can induce NF-κB,
Toll but not IL-1 activates the AP-1 transcription factor
(our unpublished observations). The integration of
signals from one or more TLRs seems more likely to be
the driving force in determining the outcome of the
response, and this means that extensive studies of mice
lacking various TLRs and of the effects of these deficien-
cies on various infectious agents need to be carried out.
This is a tall order, but it is likely to yield decisive infor-
mation on the biological function of each TLR.
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